What is ESLOF stock price today?

Visit our real-time dashboard for the current ESLOF stock price and live market data.

Is ESLOF stock going up or down today?

ESLOF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ESLOF stock now?

The decision to buy ESLOF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ESLOF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ESLOF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ESLOF stock overvalued or undervalued?

ESLOF currently trades at a P/E ratio of 49.50, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ESLOF is fairly priced.

What is ESLOF's P/E ratio?

ESLOF has a price-to-earnings (P/E) ratio of 49.50, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ESLOF's market cap?

ESLOF (EssilorLuxottica Société anonyme) has a market capitalization of $137.42 billion, making it a mid-cap stock.

What is ESLOF's price to book ratio?

Price-to-book ratio for ESLOF is available on our dashboard along with other valuation metrics.

Does ESLOF pay dividends?

Yes, ESLOF pays dividends with a current yield of 1.65%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is ESLOF's dividend yield?

ESLOF's dividend yield is 1.65%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is ESLOF stock a good long-term investment?

ESLOF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ESLOF's revenue growth rate?

Revenue growth data for ESLOF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ESLOF are available on our dashboard with complete income statement analysis.

What are the risks of investing in ESLOF?

Key risks for ESLOF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ESLOF compare to its competitors?

Compare ESLOF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ESLOF's performance and positioning.

What is ESLOF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ESLOF with bull, base, and bear case scenarios.

What do analysts say about ESLOF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ESLOF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ESLOF's next earnings report?

ESLOF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ESLOF - EssilorLuxottica Société anonyme

NYSE * Healthcare * Medical Instruments & Supplies

$0.00

+$0.00 (+0.00%)

About EssilorLuxottica Société anonyme

EssilorLuxottica Société anonyme (ESLOF) common stock

Price Chart

Loading chart...

ESLOF Key Statistics

Market Cap

$137.42B

P/E Ratio

49.50

Dividend Yield

1.65%

How ESLOF Compares to Peers

ESLOF ranks 2nd most undervalued by P/E ratio among peers

ESLOF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 3

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 3

Company	Market Cap	P/E	Growth	Margin	Compare
ESLOF(This stock)	$137.42B	49.5	0%	0.0%	-
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: June 15, 2026 at 8:53 AM EDT

Ready to invest in ESLOF?

Commission-free trading available. Affiliate links.

Upcoming Events for ESLOF

Dashboard

Enter a ticker to analyze